MYCN and lung carcinoma: Dysregulation of MYCN is observed in various tumors in both pediatric and adult settings, encompassing neuroblastoma, Wilms’ tumor, rhabdomyosarcoma, lung cancer, medulloblastoma, retinoblastoma and basal cell carcinoma (5–8, 36–41).